Cesium carbonate → HCID 67211458, compound

HRID 2040571Notes

Reaction equation

HRID 2040571 reaction equation
[OH:1][C:2]1[CH:10]=[CH:9][C:8]2[NH:7][C:6]3[CH:11]([CH2:14][C:15]([O:17][CH2:18][CH3:19])=[O:16])[CH2:12][CH2:13][C:5]=3[C:4]=2[CH:3]=1.C(=O)([O-])[O-].[Cs+].[Cs+].CS(O[CH2:31][C:32]1[CH:37]=[CH:36][C:35]([C:38]2[CH:43]=[N:42][CH:41]=[CH:40][N:39]=2)=[CH:34][CH:33]=1)(=O)=O>CN(C=O)C>[N:39]1[CH:40]=[CH:41][N:42]=[CH:43][C:38]=1[C:35]1[CH:36]=[CH:37][C:32]([CH2:31][O:1][C:2]2[CH:10]=[CH:9][C:8]3[NH:7][C:6]4[CH:11]([CH2:14][C:15]([O:17][CH2:18][CH3:19])=[O:16])[CH2:12][CH2:13][C:5]=4[C:4]=3[CH:3]=2)=[CH:33][CH:34]=1

Participants

5

Procedure

To a mixture of ethyl 2-(7-hydroxy-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetate (20 mg, 0.077 mmol) and cesium carbonate (38 mg, 0.12 mmol) in DMF (1 mL) was added 4-(pyrazin-2-yl)benzyl methanesulfonate (41 mg, 0.15 mmol). The reaction mixture was stirred at room temperature overnight. The solid was filtered, and the filtrate was concentrated. The residue was purified by preparative TLC to give the title compound (15 mg). LCMS m/z=428.3 [M+H]+. 1H NMR (400 MHz, CDCl3) δ 1.30 (t, J=7.1 Hz, 3H), 2.07-2.14 (m, 1H), 2.50 (dd, J=16.7 and 11.2 Hz, 1H), 2.70-2.87 (m, 4H), 3.50-3.57 (m, 1H), 4.18-4.24 (m, 2H), 5.18 (s, 2H), 6.87 (dd, J=8.8 and 2.4 Hz, 1H), 7.01 (d, J=2.3 Hz, 1H), 7.21 (d, J=8.7 Hz, 1H), 7.62 (d, J=8.2 Hz, 2H), 8.03 (d, J=8.3 Hz, 2H), 8.46 (s, 1H), 8.51 (d, J=2.5 Hz, 1H), 8.64 (dd, J=2.3 and 1.6 Hz, 1H), 9.04 (d, J=1.4 Hz, 1H).

Workup

  1. filtrationThe solid was filtered
  2. concentrationthe filtrate was concentrated
  3. customThe residue was purified by preparative TLC

Sources & evidence

ORD record
ord-bcb07becc1704236a695e4edb7a1f7a3
Source dataset
uspto-grants-2013_11
Patent number
US08580841B2

Reaction notes

Loading…